Overview

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of an escitalopram combination treatment compared to single treatments, and to placebo in patients with major depressive disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Pharmacology Research Institute
Treatments:
Citalopram
Dexetimide